(Q54115501)

English

Pharmacokinetic and pharmacodynamic studies with 4'-epi-doxorubicin in nasopharyngeal carcinoma patients.

scientific article published in January 1989

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2758564

Pharmacokinetic and pharmacodynamic studies with 4'-epi-doxorubicin in nasopharyngeal carcinoma patients. (English)

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2758564

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

O Y Hu

1

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2758564

S P Chang

2

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2758564

J M Jame

3

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2758564

K Y Chen

4

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2758564

publication date

1 January 1989

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2758564

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2758564

24

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2758564

5

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2758564

332-337

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2758564

https://scigraph.springernature.com/pub.10.1007/bf00304769

0 references

Phase-II clinical trial of 4'-epi-doxorubicin in metastatic solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2758564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-performance liquid chromatographic method for pharmacokinetic studies on the new anthracycline 4-demethoxydaunorubicin and its 13-dihydro derivative

1 reference

https://pubmed.ncbi.nlm.nih.gov/2758564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between activity and amino sugar stereochemistry of daunorubicin and adriamycin derivatives

1 reference

https://pubmed.ncbi.nlm.nih.gov/2758564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary phase I study of 4'-epi-adriamycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2758564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative pharmacokinetics of doxorubicin and epirubicin in patients with gastrointestinal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2758564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic studies of 4'-epi-doxorubicin in cancer patients with normal and impaired renal function and with hepatic metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/2758564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of 4'-epi-doxorubicin in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/2758564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative pharmacokinetic study of adriamycin and 4'epi-adriamycin after their simultaneous intravenous administration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2758564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved method for the determination of 4'-epidoxorubicin and seven metabolites in plasma by high-performance liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/2758564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CSTRIP, a Fortran IV Computer Program for Obtaining Initial Polyexponential Parameter Estimates

1 reference

https://pubmed.ncbi.nlm.nih.gov/2758564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative pharmacokinetics and metabolism of doxorubicin and epirubicin in patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2758564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the lethal and kinetic effects of doxorubicin and 4'-epi-doxorubicin in vitro.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2758564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of 4'-epi-doxorubicin in advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2758564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II clinical evaluation of 4'-epi-doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2758564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/2758564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on the comparative distribution and biliary excretion of doxorubicin and 4'-epi-doxorubicin in mice and rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/2758564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00304769

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2758564

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2758564

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54115501&oldid=2143961452"